Supplementary Figure 4 from Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer

Authors:

Abstract
Figure S4 shows the raw multiplex serum cytokine analysis data from Figure 4, and the antibody list and the gating strategy for the CyTOF analysis, all performed on the peripheral blood samples.
Keywords